Corvus Pharmaceuticals Inc (CRVS)
8.94
+0.70
(+8.50%)
USD |
NASDAQ |
Nov 21, 16:00
8.90
-0.04
(-0.45%)
After-Hours: 20:00
Corvus Pharmaceuticals EPS Diluted (Quarterly): -0.60 for Sept. 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.60 |
| June 30, 2024 | -0.07 |
| March 31, 2024 | -0.12 |
| December 31, 2023 | -0.13 |
| September 30, 2023 | -0.12 |
| June 30, 2023 | -0.14 |
| March 31, 2023 | -0.17 |
| December 31, 2022 | -0.21 |
| September 30, 2022 | -0.32 |
| June 30, 2022 | -0.18 |
| March 31, 2022 | -0.18 |
| December 31, 2021 | -0.20 |
| September 30, 2021 | -0.24 |
| June 30, 2021 | -0.28 |
| March 31, 2021 | -0.34 |
| December 31, 2020 | 0.92 |
| September 30, 2020 | -0.33 |
| June 30, 2020 | -0.36 |
| March 31, 2020 | -0.44 |
| December 31, 2019 | -0.38 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.37 |
| June 30, 2019 | -0.44 |
| March 31, 2019 | -0.40 |
| December 31, 2018 | -0.36 |
| September 30, 2018 | -0.36 |
| June 30, 2018 | -0.40 |
| March 31, 2018 | -0.63 |
| December 31, 2017 | -0.58 |
| September 30, 2017 | -0.62 |
| June 30, 2017 | -0.73 |
| March 31, 2017 | -0.79 |
| December 31, 2016 | -0.55 |
| September 30, 2016 | -0.51 |
| June 30, 2016 | -0.43 |
| March 31, 2016 | -5.39 |
| December 31, 2015 | -0.2959 |
| September 30, 2015 | -0.3543 |
| June 30, 2015 | -2.275 |
| March 31, 2015 | -0.2151 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.60
Minimum
Sep 2024
0.92
Maximum
Dec 2020
-0.1945
Average
-0.205
Median
EPS Diluted (Quarterly) Benchmarks
| Azenta Inc | -0.10 |
| Perspective Therapeutics Inc | -0.21 |
| Atara Biotherapeutics Inc | -2.93 |
| Clearside Biomedical Inc | -0.10 |
| Quanterix Corp | -0.25 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.22M |
| Total Expenses (Quarterly) | 7.255M |
| Enterprise Value | 532.81M |
| Earnings Yield | -10.29% |